Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

Literature DB >> 33892008

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

Nahum Méndez-Sánchez¹, Luis Díaz-Orozco², Jacqueline Córdova-Gallardo³.

Abstract

Entities: Chemical

Mesh：

Year: 2021 PMID： 33892008 DOI： 10.1016/j.jhep.2021.04.021

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

Review 1. Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors: Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal: Biomedicines Date: 2021-12-31

Review 2. Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Authors: Yasser Fouad; Melissa Palmer; Minjun Chen; Arie Regev; Rajarshi Banerjee; Rob Myers; Robert Riccio; Richard Torstenson; Ramy Younes; Puneet S Arora; Henrik Landgren; Morten A Karsdal; Martin Blake; David A Shapiro; Hans-Juergen Gruss; Muhammad Y Sheikh; Dina Attia; Steven Bollipo; Alastair D Smith; Bradley Freilich; Robert G Gish; Detlef Schuppan
Journal: J Clin Transl Hepatol Date: 2021-10-22

9. Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).

Authors: Nahum Méndez-Sánchez; Luis Enrique Díaz-Orozco
Journal: Med Sci Monit Date: 2021-07-12

9 in total

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

Review 1. Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Review 2. Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Review 3. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

4. Metabolic-associated Fatty Liver Disease.

Review 5. Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update.

Review 6. Autophagy plays a double-edged sword role in liver diseases.

Review 7. MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Review 8. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep's Clothing?

9. Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).